A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
about
A critical appraisal of treatments for bipolar disorderPublication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorderThe role of lamotrigine in the management of bipolar disorderCombination quetiapine therapy in the long-term treatment of patients with bipolar I disorder.Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizerReview of pharmacological treatment in mood disorders and future directions for drug development.The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmLithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release FormulationsAripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literatureThe effectiveness of anticonvulsants in psychiatric disordersA multiple imputation method for sensitivity analyses of time-to-event data with possibly informative censoring.Sensitivity analysis for missing outcomes in time-to-event data with covariate adjustment.Bipolar disorder.Changes in clinical trials methodology over time: a systematic review of six decades of research in psychopharmacologyA neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy.Olanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study.Burden of illness in bipolar depression.The diagnosis and treatment of bipolar disorder: decision-making in primary care.Managing bipolar depressionLURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDYLithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis.Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?Testing random effects in the linear mixed model using approximate bayes factorsTreatment implications of predominant polarity and the polarity index: a comprehensive review.The pharmacological management of depressionAcute and long-term treatment of mania.Bipolar depression: trial-based insights to guide patient care.The suicide prevention effect of lithium: more than 20 years of evidence-a narrative reviewMulti-state outcome analysis of treatments (MOAT): application of a new approach to evaluate outcomes in longitudinal studies of bipolar disorder.Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder.Gabapentin's minimal action on markers of rat brain arachidonic acid metabolism agrees with its inefficacy against bipolar disorder.Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot studyChronic clozapine reduces rat brain arachidonic acid metabolism by reducing plasma arachidonic acid availability.Lamotrigine-associated reversible severe hepatitis: a case report.A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder.Post-acute effectiveness of lithium in pediatric bipolar I disorder.Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder.Bipolar depression: clinically missed, pharmacologically mismanaged.Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior.Comparison of cognitive effects of lamotrigine and oxcarbazepine in epilepsy patients.
P2860
Q24613657-29427DD2-F661-41DC-98D2-9B68C81B82F8Q24643545-BCE5DAD4-29DB-4ECB-891F-BAB400BC7FD8Q24658110-500802E8-EB80-496E-BC36-F174D3F6734DQ24814468-4BE266C3-F719-46D8-ADA6-CFB007C35930Q26777966-0E31879A-1924-4831-98DB-F13BAD54564FQ26853509-4839BC67-02A6-41D8-B72E-80ACBF7CF0E9Q28066714-027D86AB-0E44-493A-A84A-65D8F02445D3Q28076935-10A637D1-DE12-44F7-86FA-BF67D642D0A4Q28478032-BEB8CC8E-9628-409F-8513-1761D317C69AQ28744504-541E974E-4906-4CA4-8772-415332657D7EQ30773086-B2AF96C3-0B91-4BC4-BDE0-119DC6E96B43Q30886739-72054795-0781-4669-9AC3-ACE272CEF5CDQ33448290-72BFECE4-5A91-4FC9-BD96-C2ECB8027E83Q33538059-D90FF706-B93A-4D30-B3DE-2EF09F391743Q33658525-42CE7F97-0588-45A3-8B93-C2A874D5D87AQ33673618-92363993-A7F9-4A4E-A65A-E0B7F4666C3DQ34248110-1538EFA1-1CCF-4813-9C27-4953A883F451Q34331882-A495352D-224F-4B91-992B-C5FA5002305FQ34343896-E7A39C90-B86C-4213-A079-C5D50AC4B8B1Q34515834-79D1B63B-14E4-4FC9-A695-57FF3BE8E06AQ34744822-9D5E70DF-CCFE-43FC-91CC-C65C7D860CD1Q34809427-0A61EDC3-E5C8-49AF-BF70-D88C84B15625Q35105419-E7FF44EB-0C08-4FA0-84F1-D84098DD5B4CQ35203680-EFF38689-D0F2-4425-B3E8-979BF72099EDQ35236630-D31429F8-B213-4D5C-BAF8-404AB536B067Q35236966-5981D2C8-EF66-495F-9061-B501672C7AA2Q35236988-60287BC1-6F63-467C-8CF7-E97C3E5C71ABQ35858926-8774E965-7E20-4965-AD0D-F6707ED15770Q36069919-2D4F3A6B-5670-4D74-8A66-D846B965D5B5Q36162402-B5686657-9A9A-4A01-A236-8071B37B2AC9Q36199755-79CD5750-3A40-4846-8F88-20C76E3DA405Q36233958-280739CA-DED4-4500-93D3-8EECFB4CFBE1Q36518167-37678D24-13E6-4222-8949-E7C714225D73Q36548639-B2486F92-A86E-46DF-80B3-BC4ED7C731B8Q36560064-6AFEAD1C-6F12-4503-9498-49958D8982E9Q36720669-87E61100-F40F-440E-A570-9C17A19ECC6AQ36806521-CA1FD326-774D-4A98-BC85-E7EFF758D40DQ37078950-2B1D2D13-6C2C-445C-BBD5-631C9C130810Q37158292-0CD627D6-82B2-4AC8-8373-25C6700E8E9AQ37203504-BA895813-B491-43C7-B68D-5E17F01513C8
P2860
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
A placebo-controlled 18-month ...... ients with bipolar I disorder.
@en
A placebo-controlled 18-month ...... ients with bipolar I disorder.
@nl
type
label
A placebo-controlled 18-month ...... ients with bipolar I disorder.
@en
A placebo-controlled 18-month ...... ients with bipolar I disorder.
@nl
prefLabel
A placebo-controlled 18-month ...... ients with bipolar I disorder.
@en
A placebo-controlled 18-month ...... ients with bipolar I disorder.
@nl
P2093
P356
P1476
A placebo-controlled 18-month ...... tients with bipolar I disorder
@en
P2093
Charles L Bowden
Gary Sachs
John Ascher
Joseph DeVeaugh-Geiss
Joseph R Calabrese
Kirsten Behnke
Lakshmi N Yatham
Lamictal 605 Study Group
Nancy Earl
Olli-Pekka Mehtonen
P304
P356
10.4088/JCP.V64N0906
P577
2003-09-01T00:00:00Z